Stepan Company (SCL): A Bull Case Theory

We came crossed a bullish thesis connected Stepan Company connected Danny’s Substack’s Substack by Danny Green. In this article, we volition summarize the bulls’ thesis connected SCL. Stepan Company's stock was trading astatine $66.46 arsenic of February 17th. SCL’s trailing and guardant P/E were 33.73 and 19.01 respectively according to Yahoo Finance.

Syda Productions/Shutterstock.com

Stepan Company operates crossed diversified chemic extremity markets, including surfactants, polyols, and specialty additives, which helps blunt the interaction of single-point shocks from commodity oregon vigor terms swings. While macro factors similar petrochemical feedstock costs and concern request cycles matter, the company’s diversified extremity markets—auto, construction, agrochemicals, and consumer—provide resilience.

Q3 2025 results illustrated this dynamic: consolidated nett income reached astir $590.3 million, with planetary volumes rising ~1% year-over-year. Adjusted EBITDA grew ~6% to $56.2 million, and currency from operations totaled $69.8 million, generating escaped currency travel of ~$40.2 million, highlighting near-term currency procreation contempt mixed borderline pressures. GAAP nett income, however, fell sharply by 54% to $10.8 million, driven by higher interest, taxes, and an $8.6 cardinal pre-tax resistance from the Pasadena, TX alkoxylation start-up. Segment show was mixed—Polymers & Specialty showed strength, portion Surfactants faced feedstock ostentation and start-up effects.

Management remains pragmatic and transparent, emphasizing start-up costs, feedstock pressures, and ongoing superior allocation, including continued dividends. Key operational risk centers on the Pasadena commissioning; execution issues oregon outgo overruns could materially interaction margins. Additional downside stems from sustained commodity spikes oregon large measurement declines successful concern extremity markets. Upside catalysts see palmy Pasadena ramp, feedstock stabilization, continued Polymers strength, affirmative EBITDA surprises, oregon peculiar dividends funded by escaped currency flow.

Valuation is charismatic comparative to normalized EBITDA, with dependable currency conversion providing downside protection. For investors, Stepan represents a halfway cyclical concern allocation, with prudent portfolio sizing of 1–3% conservatively and 3–6% for progressive positioning, conditional connected near-term operational de-risking and feedstock easing. The marketplace is positioned to reward operational execution and normalized margins.

Previously, we covered a bullish thesis on Eastman Chemical Company (EMN) by Necessary-Damage5658 successful November 2024, which highlighted its regulatory compliance vantage and quality to seizure marketplace stock from restricted competitors. EMN’s banal terms has depreciated by astir 21.73% since our coverage. Danny Green shares a akin presumption but emphasizes Stepan Company’s diversified extremity markets, resilience to commodity cycles, and beardown near-term currency flow.